The contribution of the sinusoidal endothelial cell receptors CLEC4M, stabilin-2, and SCARA5 to VWF–FVIII clearance in thrombosis and hemostasis
Journal of Thrombosis and Haemostasis · 2023
DOI: 10.1016/j.jtha.2023.04.014 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Thrombosis and Haemostasis, 2023. Verfasst von Laura L Swystun und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada. Hauptthemen laut MEDLINE: Thrombosis, Hemostatics, von Willebrand Diseases. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, CIHR, National Institutes of Health.
Abstract (Originalsprache)
Quantitative abnormalities in factor VIII (FVIII) and its binding partner, von Willebrand factor (VWF), are associated with an increased risk of bleeding or thrombosis, and pathways that regulate the clearance of VWF-FVIII can strongly influence their plasma levels. In 2010, the Cohorts for Heart and Aging Research in Genome Epidemiology (CHARGE) on genome-wide association study meta-analysis identified variants in the genes for the sinusoidal endothelial receptors C-type lectin domain family 4 member M (CLEC4M), stabilin-2, and scavenger receptor class A member 5 (SCARA5) as being associated with plasma levels of VWF and/or FVIII in normal individuals. The ability of these receptors to bind, internalize, and clear the VWF-FVIII complex from the circulation has now been reported in a series of studies using in vitro and in vivo models. The receptor stabilin-2 has also been shown to modulate the immune response to infused VWF-FVIII concentrates in a murine model. In addition, the influence of genetic variants in CLEC4M, STAB2, and SCARA5 on type 1 von Willebrand disease/low VWF phenotype, FVIII pharmacokinetics, and the risk of venous thromboembolism has been described in a number of patient-based studies. Understanding the role of these receptors in the regulation of VWF-FVIII clearance has led to significant insights into the genomic architecture that modulates plasma VWF and FVIII levels, improving the understanding of pathways that regulate VWF-FVIII clearance and the mechanistic basis of quantitative VWF-FVIII pathologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.
- Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada. Electronic address: https://twitter.com/michels_alison.
- Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada. Electronic address: david.lillicrap@queensu.ca.
Förderung
- NHLBI NIH HHS
- CIHR
- National Institutes of Health
- Canadian Institutes of Health Research
Zitieren
APA
Swystun, L. L., Michels, A., & Lillicrap, D. (2023). The contribution of the sinusoidal endothelial cell receptors CLEC4M, stabilin-2, and SCARA5 to VWF–FVIII clearance in thrombosis and hemostasis. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2023.04.014
Vancouver
Swystun LL, Michels A, Lillicrap D. The contribution of the sinusoidal endothelial cell receptors CLEC4M, stabilin-2, and SCARA5 to VWF–FVIII clearance in thrombosis and hemostasis. Journal of Thrombosis and Haemostasis. 2023. doi:10.1016/j.jtha.2023.04.014
BibTeX
@article{Swystun2023,
author = {Swystun, Laura L and Michels, Alison and Lillicrap, David},
title = {The contribution of the sinusoidal endothelial cell receptors CLEC4M, stabilin-2, and SCARA5 to VWF–FVIII clearance in thrombosis and hemostasis},
journal = {Journal of Thrombosis and Haemostasis},
year = {2023},
doi = {10.1016/j.jtha.2023.04.014}
}
EUVIMED